Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors [Phase 1]
Phase 1 study evaluating fluorescence imaging to locate renal cell carcinoma tumors in patients with kidney cancers has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma [Phase 3]
Phase 3 trial of IMA901 in combination with sunitinib for advanced/metastatic renal cell carcinoma has completed. The document does not prov…
-
CLINICAL_TRIALS trial_result · 2017-10-10Clinical Trial Update: Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors [Phase 1]
Phase 1 trial of sunitinib malate in adults with unresectable or metastatic kidney cancer and other advanced solid tumors. The study status …
-
CLINICAL_TRIALS trial_result · 2017-10-05Clinical Trial Update: Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice
This post-marketing surveillance study evaluates dosing patterns, safety, and effectiveness of INLYTA (axitinib) in real-world Taiwan practi…
-
CLINICAL_TRIALS trial_result · 2017-09-27Clinical Trial Update: Interleukin-2 in Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial of Interleukin-2 in metastatic kidney cancer has been terminated; results posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-09-14FDA Approved: MVASI — Original Application (Amgen, Inc)
The FDA approved MVASI (bevacizumab-awwb) from Amgen as a biosimilar to Avastin, marking the original application granting U.S. approval for…
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma [Phase 4]
A Phase 4 clinical trial update reports completion of a study evaluating first-line pazopanib in poor-risk patients with metastatic renal ce…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer [Phase 3]
A Phase 3 trial comparing sunitinib to placebo in patients at high risk of recurrent renal cell cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Optimizing Pazopanib Exposure in RCC Patients [Phase 2]
A Phase 2 trial in locally advanced or metastatic renal cell carcinoma evaluating pazopanib exposure has been terminated.
-
CLINICAL_TRIALS research · 2017-08-17Clinical Trial Update: Adjuvant Antigen Specific Immunotherapy in Patients With Advanced Renal Cell Carcinoma Using Tumor Associated Peptides [Phase 1, Phase 2]
This document provides a clinical trial update for a Phase 1/Phase 2 adjuvant antigen-specific immunotherapy using tumor-associated peptides…
-
CLINICAL_TRIALS research · 2017-08-01Clinical Trial Update: Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) [NA]
A completed clinical trial update describing the characterization of circulating tumor cells captured via c-MET (CTC-MET) across multiple ca…
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma [NA]
This clinical trial update reports on the relationship between safety endpoints and everolimus trough blood levels in advanced renal cell ca…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib [Phase 4]
Phase 4 trial assessing safety and efficacy of everolimus in metastatic renal cell carcinoma after failure of first-line therapy with suniti…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma [Phase 3]
Phase 3 trial comparing cabozantinib to everolimus in metastatic renal cell carcinoma has completed with results posted in 2017.
-
CLINICAL_TRIALS withdrawal · 2017-07-17Clinical Trial Update: Healthcare Cost and Resource Utilization Related to Metastatic Renal Cell Carcinoma Treatment With Intravenous and Oral Agents
A clinical trial evaluating healthcare costs and resource utilization for metastatic renal cell carcinoma treatments using intravenous and o…
-
CLINICAL_TRIALS research · 2017-07-14Clinical Trial Update: Study of the Variations of the Blood Pressure After Nephrectomy for Renal Cancer (VAPANCR) [NA]
A clinical trial evaluating how blood pressure varies after nephrectomy in renal cancer patients. The current status is UNKNOWN.
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors [Phase 1, Phase 2]
The trial evaluating 18F-Fluciclatide PET/CT imaging for anti-angiogenic therapy in solid tumors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer [Phase 2]
This Phase 2 trial evaluated bevacizumab plus ixabepilone in patients with advanced renal cell carcinoma; the study completed with results p…
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating capecitabine, gemcitabine, and bevacizumab in sarcomatoid renal cell carcinoma has completed and posted results in …
-
CLINICAL_TRIALS trial_result · 2017-06-19Clinical Trial Update: Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma [Phase 2, Phase 3]
Phase 2/3 study evaluating Zirconium-89-labeled girentuximab for PET/CT imaging in renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy, radiation therapy, and/or surgery for high-risk pediatric kidney tumors; results…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI [NA]
A completed clinical trial evaluating sunitinib therapy in renal cell carcinoma, monitored with F-18 FDG PET/CT and dynamic contrast-enhance…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma [Phase 1, Phase 2]
This document notes the termination of a Phase 1/2 trial evaluating 5-azacitidine with bevacizumab in advanced renal cell carcinoma and that…
-
CLINICAL_TRIALS research · 2017-06-08Clinical Trial Update: Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions [NA]
A completed clinical trial evaluated ultrasound elastography as a diagnostic tool for solid focal lesions in the kidney and liver.
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer [NA]
A terminated clinical trial used dynamic contrast-enhanced MRI to measure the effects of pazopanib in metastatic kidney cancer, with results…